Acellular pertussis vaccines in China

Area of Science:

• Vaccinology
• Immunology
• Public Health

Background:

• Whole-cell pertussis (Pw) vaccines were produced in China from the early 1960s.
• Acellular pertussis (Pa) vaccines were introduced in 1995 and have largely replaced Pw vaccines.
• A vaccine lot release system was established in 2001 to strengthen vaccine regulation.

Purpose of the Study:

• To describe the current status of acellular pertussis (Pa) vaccine production in China.
• To outline the quality control measures implemented for Pa vaccines.
• To analyze quality control test data for Pa vaccines from 2006 to 2010.

Main Methods:

• Review of Pa vaccine production processes in China.
• Description of quality control testing protocols.
• Analysis of historical quality control data (2006-2010).

Main Results:

• Pa vaccines have been integrated into China's national immunization program.
• Pa vaccines have been subject to lot release testing since 2006.
• Analysis of quality control data from 2006-2010 provides insights into vaccine quality.

Conclusions:

• The implementation of a vaccine lot release system enhances the regulation of pertussis vaccines in China.
• The data analyzed reflects the quality control status of acellular pertussis vaccines in China.
• Continued monitoring and analysis of vaccine quality are crucial for public health.